| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |